Clinical Trial Update: Cholesterol Lowering and Residual Risk in Diabetes, Type 1 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on cholesterol-lowering strategies and residual cardiovascular risk in Type 1 diabetes, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: NYU Langone Health | Conditions: Type 1 Diabetes | Phase 4 | Status: RECRUITING